Yang, J., Chen, Y., Sun, H., Zhang, X., Wang, J., Liang, Z., . . . Yang, Y. (2023). Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation. BMC.
Chicago Style (17th ed.) CitationYang, Jianming, et al. Tenofovir Versus Entecavir on Decreasing Risk of HBV-related Hepatocellular Carcinoma Recurrence After Liver Transplantation. BMC, 2023.
MLA (9th ed.) CitationYang, Jianming, et al. Tenofovir Versus Entecavir on Decreasing Risk of HBV-related Hepatocellular Carcinoma Recurrence After Liver Transplantation. BMC, 2023.
Warning: These citations may not always be 100% accurate.